Amphastar Pharma (AMPH) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018
May 9, 2018 4:05 PM EDTReports Net Revenues of $58.4 Million for the Three Months Ended March 31, 2018
RANCHO CUCAMONGA, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months ended March 31, 2018.
First Quarter Highlights
Net revenues of $58.4 million for the first quarterGAAP net loss of $7.2 million, or $0.16 per share, for the first quarterAdjusted non-GAAP net loss of $2.5 million, or $0.05 per share, for the first quarterDr. Jack Zhang, Amphastars CEO, commented:Â We are pleased to announce that we have... More
